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ABSTRACT
Objectives: To investigate the complications of the oocyte retrieval procedure currently used in in vitro fertilisation.
Material and methods: We examined 1.031 patients who underwent oocyte retrieval in the IVF unit of our hospital for 
complications developed during and after the procedure.
Results: No complications developed related to sedation or general anaesthesia. Vaginal bleeding was observed in 3.1% 
of the patients. There was no intra-abdominal bleeding or pelvic organ injuries requiring surgery. Two patients developed 
pelvic abscesses. Ovarian hyperstimulation syndrome (OHSS) occurred in 1.45% of the patients. Almost all of the patients 
tolerated the oocyte retrieval process well. After the procedure, only 2% of the patients described their pain as severe, and 
0.4% as the worst pain they had ever experienced.
Conclusions: The most common complication during oocyte retrieval is vaginal bleeding, which is largely controlled by 
buffer application. In conclusion, the oocyte retrieval process can be considered a safe procedure.
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INTRODUCTION
Even though oocyte retrieval (oocyte pick-up, OPU) 
comprises a relatively small proportion of the lengthy in 
vitro fertilisation (IVF) treatment process, it is important 
to perform the procedure with the correct technique to 
maintain the maximum oocyte count and avoid potential-
ly life-threatening complications. In this context, the OPU 
procedure is critical for successful IVF treatment outcomes.
Oocyte collection involves aspirating the fluid-filled ova-
rian follicles that contain eggs through a needle adapted 
for transvaginal ultrasonography (TvUSG) probes. Whereas 
oocyte collection has been performed laparoscopically in the 
past, transvaginal ultrasound-guided oocyte aspiration under 
intravenous sedation is now the standard technique [1]. This 
procedure was first described by Wickland et al.  [2] in 1985 and 
is widely used today in the practice of assisted reproductive 
techniques [3, 4]. This simple, effective, and popular method 
represents the gold standard technique. However, despite 
these advantages, surgery- or infection-related complications 
may occur during OPU. The most common complication is 
bleeding from the lateral fornix through which the OPU needle 
passes. In addition, complications may occur due to injury to 
the pelvic organs and vessels caused by the aspiration needle, 
infection occurring duration the treatment process, or ana-
esthesia [5–10]. Because many of the complications related to 
this procedure are underreported, it is not possible to present 
accurate data about the exact incidence of complications.
OBJECTIVES
The objective of this study was to investigate the complica-
tions that developed during and after transvaginal ultrasound-
-guided oocyte aspiration procedures performed in the IVF 
unit of our hospital, and to evaluate the pain experienced by 
patients during the procedure in the context of the literature.




In this study, we evaluated 1.031 patients who were 
referred to the IVF unit of the Suleymaniye Obstetrics and 
Gynaecology Training and Research Hospital between Octo-
ber 1, 2005 and April 30, 2008 with diagnoses of primary or 
secondary infertility, were scheduled for IVF or intracytopla-
smic sperm injection (ICSI), and underwent OPU. This study 
was approved by our institutional training and planning 
coordination committee, and used a retrospective design. 
No age restriction was applied in the selection of patients. All 
of the patients included in the study were contacted via 
telephone. Patients who could not be contacted were exc-
luded from the study.
Oocyte retrieval procedure
The patients underwent controlled ovarian hypersti-
mulation using standard long-term gonadotropin releasing 
hormone (GnRH) agonist (long protocol), microdose, or 
antagonist protocols.
Follow-up was performed with serial TvUSG and serum 
oestradiol (E2) measurements. Ovulation was triggered with 
10,000 IU human chorionic gonadotropin (hCG) (Pregnyl, 
5,000 IU amp; Organon International, Oss, Netherlands) when 
follicular size (dominant follicle larger than 18 mm or at least 
two follicles ≥ 17 mm) and E2 levels were appropriate.
OPU was carried out 34–36 h after hCG administration. 
It was recommended that the bladder be emptied prior to 
the procedure, to reduce the potential for bladder injury and 
facilitate access to the ovaries during transvaginal oocyte 
retrieval. Because the procedure is usually completed within 
5–10 min, it is not necessary to insert a probe.
The patients were placed on the gynaecological exa-
mination table in the lithotomy position and covered with 
sterile disposable covers. The gynaecologist cleansed the 
entire vulva and vagina with sterile saline while wearing 
a disposable box apron and sterile powder-free gloves. The 
vaginal ultrasonic probe was covered with a sterile plastic 
sheath. Sedoanalgesia was performed using a combina-
tion of propofol/diprivan (Astra Zeneca, Istanbul, Turkey), 
and fentanyl/fentanyl citrate (Abbott Laboratories, Abbott 
Park, IL, USA). Some patients were all given a paracervical 
block using 20 mL 1% plain lignocaine as is usual practice 
in our unit. Following insertion of the ultrasound guide for 
the vaginal probe, the OPU procedure was performed with 
a No. 16 single-lumen needle, plus a needle with a valve 
system for flushing (Cook Medical, Inc., Bloomington, IN, 
USA), under Sedoanalgesia and guidance by USG . The ul-
trasound equipment was Voluson-I with a 5- to 9-MHz 4D 
intracavitary probe (GE Healthcare).
Vaginal and/or abdominal bleeding occurring during 
and after the OPU procedure was recorded. Incidences 
of bleeding stopped by local compression, or by use of 
vaginal tamponade or sutures, were recorded. After the 
OPU procedure, the patients were held under observation 
for 2. Preventive antibiotics were not used. At discharge, the 
patients were questioned to rank their amount of pain 2 h 
after oocyte aspiration as to whether they experienced pain, 
and their self-reported degree of pain was recorded using 
a verbal descriptor scale (VDS) (pain score of 0–5. 0 — no 
pain; 1 — mild pain; 2 — moderate pain; 3 — severe pain; 
4 — very severe pain; 5 — pain was the worst they that had 
ever felt) [11, 12]. The presence of fertilisation was assessed 
16–18 h after OPU. All patients underwent embryo transfers 
on the third day following the OPU procedure.
After the OPU procedure, all patients were administered 
600 mg/day intravaginal intramuscular progesterone (Pro-
gestan, 100 mg soft capsule; Koçak Ilac, Istanbul, Turkey) 
and/or intramuscular Crinone (8% vg gel; (Serono Labo-
ratories, Norwell, MA, USA), plus1, 500 mg IU hCG every 
3 days (Pregnyl; Organon International) to provide luteal 
phase support.
The patients were administered βhCG tests 12 days after 
the transfer. Positive test outcomes were recorded.
Clinical pregnancy was determined as the detection 
of a foetal heart beat by abdominal sonography 8 weeks 
after IVF. Miscarriage was defined as the loss of a clinical 
pregnancy before the 13th week of gestation. The rates 
of implantation, clinical pregnancy ,miscarriage abortion , 
ectopic pregnancy were calculated.
Additionally, all patients were contacted by telephone 
2 months after OR and asked for complications, hospital 
admissions or any episodes of unexplained fever
RESULTS
A total of 1.031 patients who participated in assi-
sted reproductive cycling and underwent OPU were in-
cluded in this study. The mean age of the patients was 
33.92 ± 6.71 years, and the mean body mass index (BMI) 
was 24.63 ± 6.49 kg/m2. Of the patients, 583 (56.6%) had 
previously experienced operations with laparotomy and/or 
laparoscopic methods. Embryo transfer was performed in 
803 of the 1.031 patients who underwent OPU. Patient ages, 
BMIs, and previous surgical procedures are shown in Table 1.
The mean number of previous IVF attempts among 
these patients was 2.01 ± 0.57 based on medical records. Se-
doanalgesia was applied in 1.003 patients, and a local ana-
esthesia in 28 patients. The mean number of oocytes col-
lected per patient was 8.93 ± 4.69, and the mean number 
of embryos transferred was 2.07 ± 0.60. The total number of 
transferred embryos was 2.413. The total number of implan-
ted embryos was 437. The implantation rate was calculated 
as 18.1%. ICSI was performed in 982 cycles, and IVF in 49 cyc-
les. The clinical pregnancy rate was 26.9% (278/1.031) based 
3Selin Özaltın et al., Complications after oocyte retrieval
www. journals.viamedica.pl/ginekologia_polska
on the number of OPUs performed. Pregnancies resulted in 
abortion in 28.57% of cases (64/274), while the rate of ecto-
pic pregnancies was 4.64% (10/274). The rate of continuing 
pregnancies was 19.55% (204/1.031) (Tab. 1)
No complications related to anaesthesia developed. Vagi-
nal bleeding occurred in 32 (3.1%) patients during and after 
OPU. The bleeding was stopped with local compression in 
25 (2.4%) of these patients, while vaginal tamponade was 
applied in 0.05% of the patients (n = 5) for 2h. Only 0.2% of 
the cases (n = 2) required sutures. There were no complica-
tions during and after embryo transfer in the patients that 
required sutures (Tab. 2). Of the patients who experienced 
OHSS, one patient was hospitalised due to abdominal pain 
and tenderness. Of the patients included in the study group, 
1.45% (15/1.031) were hospitalised for OHSS and subsequen-
tly treated; severe OHSS (ovaries larger than 12 cm, abdominal 
distension, nausea, vomiting, diarrhoea, rapid weight gain, 
dyspnoea, haemoconcentration, and coagulation disorders) 
was detected in five of these patients. Moderate OHSS (ab-
dominal distension, abdominal swelling, mild pain, nausea, 
ascites detected on USG, and ovaries between 10−12 cm) 
was found in 10 patients. Thirty-two cases of mild OHSS were 
followed up as outpatients by treatment with analgesics and 
fluid replacement. A positive pregnancy was observed in 4 of 
the severe OHSS cases, 7 of the moderate OHSS cases, and 
15 of the mild OHSS cases. No pelvic organ injuries or major 
vascular injuries were observed in any patient.
Two patients developed abscesses after the OPU pro-
cedure. These patients were hospitalised due to abdominal 
tenderness and fever. No surgery-related complications 
were observed in one of the patients, who was laparoscopi-
cally operated on and underwent intra-abdominal drainage 
before being discharged 7 days later. The other patient 
who developed an abscess was treated only with antibio-
Table 1. Patients and cycles ’ characteristics
Parameters n (%)
Oocyte retrievals (n) 1031
Age at retrieval (years) 33.92 ± 6.71
Body mass index [kg/m2]a 24.63 ± 6.49
History of abdominal surgery 583/1031 (% 56.6)
• Diagnostic laparoscopy 159/1031 (% 15.4 )
• Operative laparoscopy 292/1031 (% 28.3)
• Laparotomy 44/1031 (%4.3)
• Laparotomy + laparoscopy 88/1031 (% 8.5)
Anaesthesia
Sedoanalgesia 1003 (% 97.3)
Local anaesthesia 28 (% 2.7)
IVF 49 (% 4.7)
ICSI 982 (% 95.2)
Cycle outcome
• Number of collected oocytes (n) 8.93 ± 4.69
• Two PN 3.46 ± 2.90
• Embryos transferred (n) 2.07 ± 0.60
• Cumulative embryo transfer count (n) 2413
• Cumulative number of implanted 437
Embryos count (n)
Implantation rate (%) 437/2413 (% 18.1)
Clinical pregnancies per 367/1031 (% 35.6)
Transfer
Clinical pregnancy rate 278/1031 (% 26.9)
Abortion rate 64/278 (% 23)
Ectopic pregnancy rate 10/278 (% 3.5)
Ongoing pregnancy rate 204/1031 (% 19.7)
ICSI — inkracytoplasmic sperm infertility; IVF — in vitro fertilisation; PN — pronuclear stage; PN: oocytes at the pronuclear stage mean ± standard deviation
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tics. Eight patients presented to our unit with mild fever and 
pelvic tenderness, all of which were treated on an outpatient 
basis with antibiotics (Tab. 2).
A VDS was applied to investigate the pain experienced 
by the patients following OPU. It was found that 40.7% 
(420/1.031) of the patients did not feel any pain, 42% 
(433/1.031) had mild pain, 15.5% (160/1.031) had modera-
te pain, and 1.6% (16/1031) experienced severe pain; 0.4% 
(4/1.031) had very severe pain; 0% (0/1031) reported that the 
pain was the worst they that had ever felt. Pain status and 
pain scores are shown in Figure 1. Only 2.1% of the patients 
remembered experiencing pain 24–72 hours after OPU.
DISCUSSION
Although the risk of serious complications due to OPU 
is quite low, various complications related to the procedure 
have been reported, including infection; bladder, bowel, 
appendix, and ureteral injuries; vaginal bleeding at the en-
trance of the needle; and minimal to massive bleeding due 
to needle injuries to pelvic veins [5−10].
This retrospective study of 1.031 patients showed that 
OPU is a safe and well-tolerated procedure. In this study, 
there were no anaesthetic complications in patients who 
underwent sedoanalgesia or local anaesthesia. Two studies 
in the literature reported complications due to anaesthesia 
performed for OPU. In the first study, conducted by Chiurgate 
et al. on a series of 542 patients, intensive care was needed for 
two patients due to bronchospasm, which occurred after ge-
neral anaesthesia. Chiurgate et al. and considered these two 
cases as a random incidence [10]. The second complication 
type, described in a case report by Ayestaran et al. (2000), was 
cardiac conduction disorder, which occurred in a patient who 
received paracervical anaesthesia with 400 mg mepivacaine 
[13]. Aside from these cases, no other anaesthesia-induced 
complications were found in the literature [14, 15].
The risk of serious complications due to OPU is very low. 
Limited vaginal bleeding is relatively common (8%) at the 
entrance site of the OPU needle; this can often be stopped 
by compression, although suturing is sometimes required. 
[16, 17]. Acute haemorrhage from the ovary, and bleeding 
or hematomas due to vascular damage in the uterus, ovary, 
and iliac vein are very rare (0.04–0.07%), but may require sur-
gical intervention when they do occur [16, 18]. Dessole et al. 
Table 2. Complications during the procedure, hospitalisations 
occurring within 2 months after and surgery for complications
Parameters n
Complications from anaesthesia 0
Vaginal bleeding 32/1031 (% 3.1)
• Minor (instant pressure _2 min) 25/1031(% 2.4)
• Mild(Vaginal Tamponade) > 2 h 5/1031(% 0.5)
• Severe (need hospitalisation 
sutures/surgery) 2/1031(% 0.2)
Severe pain requiring hospitalisation (excluding 
OHSS) 1/1031 (% 0.09)
Injuries of pelvic organs 0
Injury of Pelvic vessel 0
Pelvic abscess 2/1031 (% 0.19)
Pelvic infections 8/1031 (% 0.77)
Ureteral lesion 0
Ureterovaginal fistulas 0
Injuries of other organs 0
Unexplained fever 1/1031 (% 0.09)
OHSS 47/1031(% 4.55)
• Severe OHSS 5/1031 (% 0.49)
• Moderate OHSS 10/1031(% 0.96)
• Mild OHSS 32/1031(% 3.1)

























Figure 1. Pain score
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reported mean blood loss after a routine OPU of 230 mL [19]. 
Bleeding may be in the form of vaginal, intraperitoneal or re-
troperitoneal bleeding. Acute intraperitoneal and retroperito-
neal bleeding may be recognised during or immediately after 
TvUSG in the absence of any observable vaginal bleeding, and 
retroperitoneal bleeding in particular may develop gradually 
and be diagnosed by USG or other imaging methods after the 
development of bleeding-induced signs. For example, cases 
of retroperitoneal hematoma (i.e. the ‘Cullen finding’), which 
have a good course and manifest as periumbilical hematoma, 
have been reported in the literature [20]. Although massive 
haemorrhages are mostly due to ovarian, uterine, and iliac 
vessel injuries, cases of massive retroperitoneal haemorrhage 
due to injury to the middle sacral vein, and cases of massive 
haematuria due to bladder pseudoaneurysm haemorrhage, 
have also been reported [21, 22]. Serious bleeding may occur 
due to clotting disorders [21, 22]. In their studies, Battaglia 
et al. (2000) and El-Shawarby et al. (2004) reported severe 
bleeding in two patients with Factor IX deficiency, and in one 
patient with essential thrombocytopenia [23, 24].
Vaginal bleeding was seen in 3.1% of our patients and in-
tra-abdominal bleeding was not observed. The bleeding was 
stopped with local compression in 25 (2.4%) patients. Vagi-
nal tamponade was applied in 0.05% of the patients (n = 5) 
for 2 h. Only 0.2% (n = 2) of the cases required sutures. Blood 
transfusion was not needed in any patient.
Pelvic structures may be traumatised by aspiration ne-
edles. Akman et al. and Roest et al. reported perforated 
appendicitis in two patients after OPU, and the needle hole 
was observed in these cases [25, 26]. Contrary to what is 
believed, intestinal injury is less common, and is more li-
kely to develop in patients with advanced endometriosis, 
previous surgery, or pelvic adhesions related to previous 
infections [27]. In our study, no intestinal injuries were obse-
rved. Although the intestines and bladder can be seen with 
ultrasound guidance, injuries to these organs may develop; 
such injuries may resolve without being noticed and dia-
gnosed. No intestinal or bladder injuries were observed in 
any of the 1.031 patients in our study, nor were any found 
on back-questioning of the patients.
Ureteral injury or ureteral obstruction has also been 
reported. Miller et al., Unsurprisingly, ureteral injuries are 
underreported, due to the anatomical position of the ureter 
anterolateral of the upper vaginal fornix [28]. No ureteral 
injuries were found in our study.
Pelvic infection or pelvic inflammatory disease (PID) may 
develop after OPU. While the incidence has been reported 
as 0.02% by the European Society of Human Reproduction 
and Embryology data, other studies report an incidence rate 
of up to 0.3−1.5% [29−30]. The most likely cause is transfer 
of vaginal bacterial medium into the peritoneal cavity fol-
lowing perforation of the vagina with the pick-up needle.
In their series of 3.656 patients, Dicker et al. found tubo-
-ovarian/pelvic abscesses in 99/3.656 (0.24%) patients. Pelvic 
infection was controlled through oophorectomy with lapa-
rotomy in three, and colpotomy in six, of these patients [18]. 
In their series of 2.495 patients, Roest et al. detected pelvic 
infection in six (0.24%) patients. These six patients were 
treated with appropriate antibiotics [26]. Askenazi et al. [31] 
found pelvic infection in 28 of 47.771 patients (0.58%). All 
28 patients were treated with appropriate antibiotics. In our 
series of 1.031 patients, we found pelvic abscesses in two 
patients (0.19%). These patients were hospitalised due to 
abdominal tenderness and fever; one of them underwent 
laparoscopic operation and the abscess was drained. No 
postoperative complications were observed, and the pa-
tient was discharged 7 days later. The other patient who 
developed an abscess was treated with antibiotics alone. 
Eight patients were referred to our unit with complaints 
of mild fever and pelvic tenderness. All of these patients 
were treated on an outpatient basis with antibiotic therapy.
The pain caused by the OPU procedure was well-tole-
rated by patients. We observed that the pain increased in 
direct proportion to the number of oocytes collected and 
repeated passage through the vaginal fornices. This was 
due to the high rate of transvaginal access. In their series of 
1.166 patients, Ludwig et al. [32] questioned patients about 
their pain level 2 h after the OPU procedure.: 16.9% reported 
moderate pain, and 3.1% severe or very severe pain. Further-
more, whereas 7.6% of patients experienced moderate pain 
2 days after OPU, 1.7% experienced severe or very severe 
pain. In total, 7 out of 1.166 patients required hospitalisa-
tion due to severe pain [32]. In our study, 40.7% (420/1.031) 
of patients did not experience any pain, 42% (433/1.031) 
experienced mild pain, 15.5% (160/1.031) moderate pain, 
1.6% (16/1.031) severe pain, and 0.4% (4/1.031) reported 
that the pain was the worst they had ever experienced. Only 
2.1% of patients, all of whom were contacted via telephone, 
remembered experiencing pain 24−72 h after OPU.
CONCLUSIONS
Although the OPU procedure is minimally invasive, the risks 
of pain and bleeding should be considered, and necessary pre-
cautions taken. Complications may be recognised immediately 
due to acute events, or they may be diagnosed later by evalu-
ating patients for latent problems. Therefore, these conditions 
should be kept in mind in the early follow-up period between 
oocyte retrieval and embryo transfer and, in later follow-ups, 
careful attention should be given to potentially unrecognised 
injuries and their consequences. Patients should be informed 
about early signs of complications that may develop later.
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